Baystate Wealth Management’s Core Laboratories CLB Stock Holding History

Baystate Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21	Closed	-$1K	–	631
2019 Q3	$1K	Buy	21 +1	+5%	+$46	﹤0.01%	518
2019 Q2	$1K	Hold	20	–	–	﹤0.01%	549
2019 Q1	$1K	Hold	20	–	–	﹤0.01%	557
2018 Q4	$1K	Hold	20	–	–	﹤0.01%	563
2018 Q3	$2K	Hold	20	–	–	﹤0.01%	516
2018 Q2	$2K	Hold	20	–	–	﹤0.01%	534
2018 Q1	$2K	Hold	20	–	–	﹤0.01%	495
2017 Q4	$2K	Hold	20	–	–	﹤0.01%	495
2017 Q3	$2K	Hold	20	–	–	﹤0.01%	479
2017 Q2	$2K	Hold	20	–	–	﹤0.01%	481
2017 Q1	$2K	Hold	20	–	–	﹤0.01%	453
2016 Q4	$2K	Buy	+20	New	+$2.21K	﹤0.01%	397
2013 Q3	–	Sell	-20	Closed	-$3K	–	57
2013 Q2	$3K	Buy	+20	New	+$2.83K	﹤0.01%	247

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Baystate Wealth Management's CLB Position: Q4 2019 in Review

Baystate Wealth Management sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 21 shares — an estimated $1K sold.

Baystate Wealth Management first reported a position in CLB in Q2 2013 and held it in 13 quarters. The position peaked at $3K in Q2 2013. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Baystate Wealth Management reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Baystate Wealth Management sold 21 Core Laboratories shares in Q4 2019, an estimated $1K.
Baystate Wealth Management first reported a position in Core Laboratories in Q2 2013 and held it in 13 quarters.
Baystate Wealth Management's Core Laboratories position peaked at $3K in Q2 2013.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Baystate Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.